Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages
Abbreviated Journal Title
Can. J. Physiol. Pharmacol.
atherosclerosis; macrophages; monocytes; IL-10; ATHEROSCLEROSIS; MONOCYTES; GROWTH; BMP-7; Pharmacology & Pharmacy; Physiology
It was hypothesized that monocyte treatment with bone morphogenetic protein 7 (BMP7) would significantly enhance monocyte polarization into M2 macrophages as well as increasing the levels of anti-inflammatory cytokines. In a cell culture system using monocytes (human acute monocytic leukemia cell line THP-1), we studied the effects of BMP7 on monocytes polarizing into M2 macrophages. The data demonstrate that THP-1 cells contain a BMP type II receptor (BMPR2), and that its activation is significantly (p < 0.05) increased following treatment with BMP7. Furthermore, there was an increase of M2 macrophages, BMPR2, and anti-inflammatory cytokines interleukin (IL)-10 and IL-1ra compared with the respective controls. Moreover, treatment with BMP7 caused a significant (p < 0.05) decrease in the levels of pro-inflammatory cytokines IL-6, tumour necrosis factor (TNF-alpha), and monocyte chemotactic protein-1 (MCP-1), compared with the controls. In conclusion, we suggest for the first time that BMP7 has a unique potential to polarize monocytes into M2 macrophages, required for tissue repair, which will have significant applications for the treatment of atherosclerosis.
Canadian Journal of Physiology and Pharmacology
"Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages" (2012). Faculty Bibliography 2010s. 3205.